Skip to content
    Drishti.money
    Earnings calls

    Shalby concall ledger

    Every earnings call for SHALBY — management tone, guidance, KPIs and promise tracking, quarter by quarter.

    SHALBY · 4 transcripts · Healthcare · latest Q3 FY26
    Q3 FY26Published 12 Feb 2026Call held 12 Feb 2026

    SHALBY Q3 FY26 Earnings Call Transcript & Analysis

    Consolidated Revenue₹279.4 cr−1% YoYConsolidated EBITDA₹37.5 cr−1% YoYConsolidated EBITDA Margin13.4%Consolidated PAT₹1.3 crConsolidated PAT Margin0.5%

    Consolidated Revenue ₹279 cr (−1% YoY); Consolidated EBITDA ₹38 cr (−1% YoY); Consolidated EBITDA Margin 13.4%. Consolidated MedTech revenue grew 29% YoY to INR 303.8 million.

    Read full transcript & analysis
    Q2 FY26Published 15 Nov 2025Call held 15 Nov 2025

    SHALBY Q2 FY26 Earnings Call Transcript & Analysis

    Consolidated Revenue₹289 cr+5% YoYConsolidated EBITDA₹46.1 cr+16% YoYConsolidated EBITDA Margin15.9%Consolidated PAT₹7.3 cr+204% YoYConsolidated PBT₹19.1 cr+39% YoY

    Consolidated Revenue ₹289 cr (+5% YoY); Consolidated EBITDA ₹46 cr (+16% YoY); Consolidated EBITDA Margin 15.9%. Consolidated revenue grew 5.5% YoY to INR289 crores.

    Read full transcript & analysis
    Q1 FY26Published 14 Aug 2025Call held 14 Aug 2025

    SHALBY Q1 FY26 Earnings Call Transcript & Analysis

    Consolidated Revenue₹303 cr+5% YoYConsolidated EBITDA₹48.5 cr−12% YoYConsolidated EBITDA Margin16%Consolidated PAT₹7.7 cr−47% YoYConsolidated PBT₹22.7 cr−26% YoY

    Consolidated Revenue ₹303 cr (+5% YoY); Consolidated EBITDA ₹48 cr (−12% YoY); Consolidated EBITDA Margin 16.0%. Consolidated revenue reached a record INR303 crores, up 5.1% YoY and 12.3% QoQ.

    Read full transcript & analysis
    Q4 FY25Published 31 May 2025Call held 31 May 2025

    SHALBY Q4 FY25 Earnings Call Transcript & Analysis

    Consolidated Revenue₹270 cr+8% YoYConsolidated EBITDA₹26.2 cr−40% YoYConsolidated EBITDA Margin9.7%Consolidated PBT₹-0.7 cr

    Consolidated Revenue ₹270 cr (+8% YoY); Consolidated EBITDA ₹26 cr (−40% YoY); Consolidated EBITDA Margin 9.7%. Consolidated revenue grew 8.4% YoY to INR 270 crores in Q4 FY25.

    Read full transcript & analysis